Covid19-Sources

4454 bookmarks
Newest
Core Concept: The pandemic is prompting widespread use—and misuse—of real-world data | PNAS
Core Concept: The pandemic is prompting widespread use—and misuse—of real-world data | PNAS
COVID-19 has swept across the world, overwhelming healthcare systems and raising countless questions about how best to diagnose patients, treat infections, save lives, and contain the pandemic. In short order, researchers have launched randomized trials to uncover pharmacologic interventions that hold the promise of preventing or lessening the severity of the disease. But getting results takes time. And time was a luxury that doctors on the frontlines of the coronavirus fight could ill afford in the early months of the pandemic. The dangers of COVID-19 present an unprecedented opportunity t...
·pnas.org·
Core Concept: The pandemic is prompting widespread use—and misuse—of real-world data | PNAS
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms | Science
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms | Science
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is closely related to the deadly coronaviruses SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV). Considerable efforts are focused on developing treatments, and therapies that work across coronaviruses would be particularly valuable. Shedding light on the host factors hijacked by the viruses, Gordon et al. mapped the interactions between viral and human proteins for SARS-CoV-2, SARS-CoV-1, and MERS-CoV; analyzed the localization of viral proteins in human cells; and used genetic screening to identify host fact...
·science.sciencemag.org·
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms | Science
Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis | medRxiv
Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis | medRxiv
Antibody-dependent enhancement (ADE) has been reported in several virus infections including dengue fever virus, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus infection. To study whether ADE is involved in COVID-19 infections, in vitro pseudotyped SARS-CoV-2 entry into Raji cells, K562 cells, and primary B cells mediated by plasma from recovered COVID-19 patients were employed as models. The enhancement of SARS-CoV-2 entry into cells was more commonly detected in plasma from severely-affected elderly patients with high titers of SARS-CoV-2 ...
·medrxiv.org·
Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis | medRxiv
Antibody Immunological Imprinting on COVID-19 Patients | medRxiv
Antibody Immunological Imprinting on COVID-19 Patients | medRxiv
While the current pandemic remains a thread to human health, the polyclonal nature of the antibody response against SARS-CoV-2 is not fully understood. Other than SARS-CoV-2, humans are susceptible to six different coronaviruses, and previous exposure to antigenically related and divergent seasonal coronaviruses is frequent. We longitudinally profiled the early humoral immune response against SARS-CoV-2 on hospitalized COVID-19 patients, and quantify levels of pre-existing immunity to OC43, HKU1 and 223E seasonal coronaviruses. A strong back-boosting effect to conserved, but not variable re...
·medrxiv.org·
Antibody Immunological Imprinting on COVID-19 Patients | medRxiv
Dynamics and significance of the antibody response to SARS-CoV-2 infection | medRxiv
Dynamics and significance of the antibody response to SARS-CoV-2 infection | medRxiv
BACKGROUND Characterizing the humoral immune response to SARS-CoV-2 and developing accurate serologic assays are needed for diagnostic purposes and estimating population-level seroprevalence. METHODS We measured the kinetics of early antibody responses to the receptor-binding domain (RBD) of the spike (S) protein of SARS-CoV-2 in a cohort of 259 symptomatic North American patients infected with SARS-CoV-2 (up to 75 days after symptom onset) compared to antibody levels in 1548 individuals whose blood samples were obtained prior to the pandemic. RESULTS Between 14-28 days from onset of sympto...
·medrxiv.org·
Dynamics and significance of the antibody response to SARS-CoV-2 infection | medRxiv
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications | Science
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications | Science
Coronavirus disease 2019 (COVID-19) has affected millions of people globally, yet how the human immune system responds to and influences COVID-19 severity remains unclear. Mathew et al. present a comprehensive atlas of immune modulation associated with COVID-19. They performed high-dimensional flow cytometry of hospitalized COVID-19 patients and found three prominent and distinct immunotypes that are related to disease severity and clinical parameters. Arunachalam et al. report a systems biology approach to assess the immune system of COVID-19 patients with mild-to-severe disease. These stu...
·science.sciencemag.org·
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications | Science
Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study) by Victoria Jane Hall, Sarah Foulkes, Ayoub Saei, Nick Andrews, Blanche Oguti, Andre Charlett, Edgar Wellington, Julia Stowe, Natalie Gillson, Ana Atti, Jasmin Islam, Ioannis Karagiannis, Katie Munro, Jameel Khawam, The SIREN Study Group, Meera A. Chand, Colin Brown, Mary E. Ramsay, Jamie Lopez Bernal, Susan Hopkins :: SSRN
Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study) by Victoria Jane Hall, Sarah Foulkes, Ayoub Saei, Nick Andrews, Blanche Oguti, Andre Charlett, Edgar Wellington, Julia Stowe, Natalie Gillson, Ana Atti, Jasmin Islam, Ioannis Karagiannis, Katie Munro, Jameel Khawam, The SIREN Study Group, Meera A. Chand, Colin Brown, Mary E. Ramsay, Jamie Lopez Bernal, Susan Hopkins :: SSRN
Background: BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have been rapidly rolled out in the UK. We determined the factors associated with vacci
·papers.ssrn.com·
Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study) by Victoria Jane Hall, Sarah Foulkes, Ayoub Saei, Nick Andrews, Blanche Oguti, Andre Charlett, Edgar Wellington, Julia Stowe, Natalie Gillson, Ana Atti, Jasmin Islam, Ioannis Karagiannis, Katie Munro, Jameel Khawam, The SIREN Study Group, Meera A. Chand, Colin Brown, Mary E. Ramsay, Jamie Lopez Bernal, Susan Hopkins :: SSRN
Preliminary Evidence on Long COVID in children | medRxiv
Preliminary Evidence on Long COVID in children | medRxiv
There is increasing evidence that adult patients diagnosed with acute COVID-19 suffer from Long COVID initially described in Italy. To date, data on Long COVID in children are lacking. We assessed persistent symptoms in pediatric patients previously diagnosed with COVID-19. More than a half reported at least one persisting symptom even after 120 days since COVID-19, with 42.6% being impaired by these symptoms during daily activities. Symptoms like fatigue, muscle and joint pain, headache, insomnia, respiratory problems and palpitations were particularly frequent, as also described in adults...
·medrxiv.org·
Preliminary Evidence on Long COVID in children | medRxiv
Friedemann Weber auf Twitter: "Aus aktuellem Anlass noch mal ein paar Erläuterungen zu Viren, Evolution und Virulenz. Zunächst: es ist nicht einfach so, dass ein virulenter (="krankmachender") Erreger automatisch schlecht adaptiert (angepasst) ist. 1/16" / Twitter
Friedemann Weber auf Twitter: "Aus aktuellem Anlass noch mal ein paar Erläuterungen zu Viren, Evolution und Virulenz. Zunächst: es ist nicht einfach so, dass ein virulenter (="krankmachender") Erreger automatisch schlecht adaptiert (angepasst) ist. 1/16" / Twitter
Aus aktuellem Anlass noch mal ein paar Erläuterungen zu Viren, Evolution und Virulenz. Zunächst: es ist nicht einfach so, dass ein virulenter (="krankmachender") Erreger automatisch schlecht adaptiert (angepasst) ist. 1/16— Friedemann Weber (@Friedemann1) February 24, 2021
·twitter.com·
Friedemann Weber auf Twitter: "Aus aktuellem Anlass noch mal ein paar Erläuterungen zu Viren, Evolution und Virulenz. Zunächst: es ist nicht einfach so, dass ein virulenter (="krankmachender") Erreger automatisch schlecht adaptiert (angepasst) ist. 1/16" / Twitter
Akute Atemwegsinfektionen: Differenzialdiagnose im Winter 2020/21
Akute Atemwegsinfektionen: Differenzialdiagnose im Winter 2020/21
Influenza, Pneumonie oder doch COVID-19? An zwei Fallbeispielen wird eine pragmatische Herangehensweise für die Diagnostik und Behandlung von akuten Atemwegsinfektionen während der anhaltenden SARS-CoV-2-Pandemie aufgezeigt. Die SARS-CoV-2-(„severe...
·aerzteblatt.de·
Akute Atemwegsinfektionen: Differenzialdiagnose im Winter 2020/21